Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL

The feasibility and efficacy of cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B ce...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of hematology 2010-12, Vol.92 (5), p.732-743
Hauptverfasser:	Maruyama, Dai, Watanabe, Takashi, Maeshima, Akiko Miyagi, Nomoto, Junko, Taniguchi, Hirokazu, Azuma, Teruhisa, Mori, Masakazu, Munakata, Wataru, Kim, Sung-Won, Kobayashi, Yukio, Matsuno, Yoshihiro, Tobinai, Kensei
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal, Murine-Derived - therapeutic use Antineoplastic Agents - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Burkitt Lymphoma - drug therapy Burkitt Lymphoma - pathology Cyclophosphamide - administration & dosage Cytarabine - administration & dosage Disease-Free Survival Doxorubicin - administration & dosage Etoposide - administration & dosage Female Hematologic and hematopoietic diseases Hematology Humans Ifosfamide - administration & dosage Infectious diseases Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoma, B-Cell - drug therapy Lymphoma, B-Cell - pathology Male Medical sciences Medicine Medicine & Public Health Methotrexate - administration & dosage Middle Aged Oncology Original Article Rituximab Treatment Outcome Vincristine - administration & dosage Viral diseases Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!